Literature DB >> 18396136

Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27.

Kimihiko Matsusue1, Takashi Kusakabe, Takahiro Noguchi, Shouichi Takiguchi, Toshimitsu Suzuki, Shigeru Yamano, Frank J Gonzalez.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPARgamma) is induced in leptin-deficient (ob/ob) mouse liver and is critical for the development of hepatic steatosis. The present study shows that fat-specific protein 27 (Fsp27) in ob/ob liver is a direct target gene of PPARgamma and can elevate hepatic triglyceride levels. FSP27 belongs to the CIDE family, composed of CIDE A, CIDE B, and FSP27/CIDE C, all of which contain a conserved CIDE-N domain. FSP27 was recently reported to be a lipid droplet-binding protein and to promote lipid accumulation in adipocytes. The Fsp27 gene was expressed at high levels in ob/ob liver and at markedly lower levels in ob/ob livers lacking PPARgamma. Forced expression of FSP27 by adenovirus in hepatocytes in vitro or in vivo led to increased triglyceride levels. Knockdown by adenovirus expressing FSP27 shRNA resulted in lower accumulation of hepatic triglycerides compared to control adenovirus-infected liver. Taken together, these results indicate that FSP27 is a direct mediator of PPARgamma-dependent hepatic steatosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396136      PMCID: PMC2587176          DOI: 10.1016/j.cmet.2008.03.003

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  36 in total

1.  C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.

Authors:  Evan D Rosen; Chung-Hsin Hsu; Xinzhong Wang; Shuichi Sakai; Mason W Freeman; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

2.  Cidea-deficient mice have lean phenotype and are resistant to obesity.

Authors:  Zhihong Zhou; Shen Yon Toh; Zhengming Chen; Ke Guo; Chee Peng Ng; Sathivel Ponniah; Sheng-Cai Lin; Wanjin Hong; Peng Li
Journal:  Nat Genet       Date:  2003-08-10       Impact factor: 38.330

3.  Pioglitazone trial for NASH: results show promise.

Authors:  Les Lang
Journal:  Gastroenterology       Date:  2007-03       Impact factor: 22.682

4.  Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa.

Authors:  A Mansén; H Guardiola-Diaz; J Rafter; C Branting; J A Gustafsson
Journal:  Biochem Biophys Res Commun       Date:  1996-05-24       Impact factor: 3.575

5.  Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins.

Authors:  Björn Magnusson; Lennart Asp; Pontus Boström; Michel Ruiz; Pia Stillemark-Billton; Daniel Lindén; Jan Borén; Sven-Olof Olofsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

6.  Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.

Authors:  Mitsutaka Inoue; Takaaki Ohtake; Wataru Motomura; Nobuhiko Takahashi; Yayoi Hosoki; Shigeki Miyoshi; Yasuaki Suzuki; Hiroyuki Saito; Yutaka Kohgo; Toshikatsu Okumura
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

Review 7.  Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.

Authors:  Philippe Gervois; Jean-Charles Fruchart; Bart Staels
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

8.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

Authors:  Kimihiko Matsusue; Martin Haluzik; Gilles Lambert; Sun-Hee Yim; Oksana Gavrilova; Jerrold M Ward; Bryan Brewer; Marc L Reitman; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

9.  PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.

Authors:  Susan E Schadinger; Nancy L R Bucher; Barbara M Schreiber; Stephen R Farmer
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-01-11       Impact factor: 4.310

10.  CCAAT/enhancer binding protein expression is rapidly extinguished in TA1 adipocyte cells treated with tumor necrosis factor.

Authors:  P M Williams; D J Chang; U Danesch; G M Ringold; R A Heller
Journal:  Mol Endocrinol       Date:  1992-07
View more
  146 in total

Review 1.  The role of lipid droplets in metabolic disease in rodents and humans.

Authors:  Andrew S Greenberg; Rosalind A Coleman; Fredric B Kraemer; James L McManaman; Martin S Obin; Vishwajeet Puri; Qing-Wu Yan; Hideaki Miyoshi; Douglas G Mashek
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Identification of differentially expressed genes between hepatocytes of Landes geese (Anser anser) and Sichuan White geese (Anser cygnoides).

Authors:  Zhixiong Pan; Jiwen Wang; Chunchun Han; Ningfeng Zhai; Jia Lv; Zehui Zhou; Hui Tang; Shuxia Xiang; Jing Wang; Liang Li
Journal:  Mol Biol Rep       Date:  2010-03-18       Impact factor: 2.316

3.  Synergistic regulation of hepatic Fsp27b expression by HNF4α and CREBH.

Authors:  Carlos Ichiro Kasano-Camones; Masayuki Takizawa; Wakana Iwasaki; Shota Sasaki; Mume Hamada; Aoi Morimoto; Masakiyo Sakaguchi; Frank J Gonzalez; Yusuke Inoue
Journal:  Biochem Biophys Res Commun       Date:  2020-06-15       Impact factor: 3.575

4.  Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.

Authors:  Jiansheng Huang; Yuzhi Jia; Tao Fu; Navin Viswakarma; Liang Bai; M Sambasiva Rao; Yijun Zhu; Jayme Borensztajn; Janardan K Reddy
Journal:  FASEB J       Date:  2011-10-18       Impact factor: 5.191

5.  Long-term ethanol consumption promotes hepatic tumorigenesis but impairs normal hepatocyte proliferation in rats.

Authors:  Pollyanna R G Chavez; Fuzhi Lian; Jayong Chung; Chun Liu; Sergio A R Paiva; Helmut K Seitz; Xiang-Dong Wang
Journal:  J Nutr       Date:  2011-04-13       Impact factor: 4.798

6.  Insulin Represses Fasting-Induced Expression of Hepatic Fat-Specific Protein 27.

Authors:  Kohei Matsuo; Kimihiko Matsusue; Daisuke Aibara; Soichi Takiguchi; Frank J Gonzalez; Shigeru Yamano
Journal:  Biol Pharm Bull       Date:  2017       Impact factor: 2.233

7.  Fsp27/CIDEC is a CREB target gene induced during early fasting in liver and regulated by FA oxidation rate.

Authors:  Anna Vilà-Brau; Ana Luísa De Sousa-Coelho; Joana F Gonçalves; Diego Haro; Pedro F Marrero
Journal:  J Lipid Res       Date:  2012-12-06       Impact factor: 5.922

8.  Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein.

Authors:  Richard G Lee; Wuxia Fu; Mark J Graham; Adam E Mullick; Donna Sipe; Danielle Gattis; Thomas A Bell; Sheri Booten; Rosanne M Crooke
Journal:  J Lipid Res       Date:  2012-12-06       Impact factor: 5.922

9.  Fat-specific protein 27 undergoes ubiquitin-dependent degradation regulated by triacylglycerol synthesis and lipid droplet formation.

Authors:  Zongqian Nian; Zhiqi Sun; Luxin Yu; Shen Yon Toh; Jianli Sang; Peng Li
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

10.  CDP-DAG synthase 1 and 2 regulate lipid droplet growth through distinct mechanisms.

Authors:  Yanqing Xu; Hoi Yin Mak; Ivan Lukmantara; Yang E Li; Kyle L Hoehn; Xun Huang; Ximing Du; Hongyuan Yang
Journal:  J Biol Chem       Date:  2019-09-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.